Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE)
- 1 August 2016
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 178, 198-205
Abstract
No abstract availableKeywords
Funding Information
- Duke University
- Novartis Pharmaceuticals Corporation
This publication has 31 references indexed in Scilit:
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012European Journal of Heart Failure, 2012
- National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008JAMA, 2011
- Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart FailureNew England Journal of Medicine, 2010
- Physician-Determined Worsening Heart Failure: A Novel Definition for Early Worsening Heart Failure in Patients Hospitalized for Acute Heart Failure – Association with Signs and Symptoms, Hospitalization Duration, and 60-Day OutcomesCardiology, 2009
- Early Worsening Heart Failure in Patients Admitted for Acute Heart Failure: Time Course, Hemodynamic Predictors, and OutcomeJournal of Cardiac Failure, 2009
- Linking inpatient clinical registry data to Medicare claims data using indirect identifiersAmerican Heart Journal, 2009
- Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study)The American Journal of Cardiology, 2008
- Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)American Heart Journal, 2005
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- The Sensitivity and Specificity of Forecasting High-Cost Users of Medical CareMedical Care, 1999